Xarelto
Showing 1 - 25 of 243
Venous Thromboembolism, Arthroplasty Trial in Chiayi City (Rivaroxaban 10 MG)
Recruiting
- Venous Thromboembolism
- Arthroplasty
- Rivaroxaban 10 MG
-
Chiayi City, TaiwanDitmanson Medical Foundation Chiayi Christian Hospital
Dec 20, 2022
Xarelto for Venous Thromboembolism (VTE)
Completed
- Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, JapanMany locations
Oct 30, 2022
Gain Information on Drug Xarelto for Prevention of Brain Attack
Completed
- Non-valvular Atrial Fibrillation (NVAF)
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, TaiwanMany Locations
Jan 29, 2023
Deep Vein Thrombosis, Chronic Portal Vein Thrombosis Trial in Clichy (Xarelto)
Completed
- Deep Vein Thrombosis
- Chronic Portal Vein Thrombosis
- Xarelto
-
Clichy, FranceHôpital Beaujon
Jul 22, 2022
ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus Trial in Chang chun (Rivaroxaban 15 MG [Xarelto])
Recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Left Ventricular Thrombus
- Rivaroxaban 15 MG [Xarelto]
-
Chang chun, Jilin, ChinaJilin university
May 28, 2023
Patient Engagement, Patient Satisfaction Trial in Los Angeles (Amazon Alexa based voice recording patient education)
Terminated
- Patient Engagement
- Patient Satisfaction
- Amazon Alexa based voice recording patient education
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Mar 7, 2022
Effectiveness of Rivaroxaban When Given Together With
Recruiting
- Prevention of Atherothrombotic Events
- +2 more
- Rivaroxaban (Xarelto,Bay 59-7939)
- Acetylsalicylic acid(ASA)
-
Multiple Locations, IndiaMany locations
Aug 22, 2022
Xarelto for Real Life Anticoagulation in Pulmonary Embolism in
Completed
- Pulmonary Embolism
- Rivaroxaban(Xarelto, BAY 59-7939)
-
Multiple Locations, ChinaMany locations
Jan 3, 2022
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Safety of Rivaroxaban in Children Under 2 Years Old With Venous
Not yet recruiting
- Venous Thromboembolism
- Children Under 2 Years
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care (SOC)
-
Multiple Locations, Denmark
- +3 more
Jun 9, 2023
Learn More About Target Population for Xarelto in French
Completed
- Peripheral Artery Disease
- Lower limb revascularization
-
Multiple Locations, FrancePMSI
Apr 22, 2022
Stroke and Non-Central Nervous Systemic Embolism in Renally
Completed
- Non-valvular Atrial Fibrillation (NVAF)
- Rivaroxaban(Xarelto,BAY 59-7939)
-
Multiple Locations, Korea, Republic ofMany locations
Dec 21, 2021
Bariatric Surgery Trial in Baden, Berne, Bern (Rivaroxaban 10 MG Oral Tablet [Xarelto])
Active, not recruiting
- Bariatric Surgery
- Rivaroxaban 10 MG Oral Tablet [Xarelto]
-
Baden, Switzerland
- +2 more
Dec 14, 2022
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Rivaroxaban Versus Low-molecular-weight Heparin and
Completed
- Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY 59-7939)
- LMWH and Phenprocoumon
-
Multiple Locations, GermanyMultiple facilities
Apr 27, 2022
Oral Anticoagulation Drugs and How Well These Drugs Work in Real
Active, not recruiting
- Atrial Fibrillation
- Rivaroxaban (Xarelto)
- +3 more
-
Multiple Locations, SwedenMany locations
Jan 20, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Learn About Venous Thromboembolism Treatment With Rivaroxaban in
Completed
- Treatment of Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Japan Databases, Japan
- +1 more
Jan 10, 2023
Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)
Recruiting
- Atherosclerosis of Artery
- +3 more
- Rivaroxaban 2.5mg
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 2, 2023
Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)
Not yet recruiting
- Healthy
- Tegoprazan 50mg
- +3 more
- (no location specified)
Feb 2, 2023
Radial Artery Occlusion Trial in Kingston, Ottawa (Rivaroxaban 15 MG Oral Tablet [Xarelto])
Recruiting
- Radial Artery Occlusion
- Rivaroxaban 15 MG Oral Tablet [Xarelto]
-
Kingston, Ontario, Canada
- +1 more
Feb 8, 2022
Atrial Fibrillation and Heart Failure Who Are ReceivingDirect
Completed
- Heart Failure
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, SpainMany Locations
Dec 29, 2022
Patient and Physician Knowledge of Key Safety Messages
Completed
- Anticoagulation
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, France
- +3 more
Apr 5, 2021
Type II Myocardial Infarction Trial in Edmonton (Rivaroxaban 2.5 MG [Xarelto], Placebo)
Recruiting
- Type II Myocardial Infarction
- Rivaroxaban 2.5 MG [Xarelto]
- Placebo
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 19, 2022